@StephensonCC ๐ซ Thoracic Onc/ Phase1. Asst Director Early Phase; Sr Director AI & Data Science @JCOPO_ASCO podcast host #FromKashmir โ #SpaceAndMedicine ๐จโ๐
Maybe an unpopular opinion, but...
If your press release claims a trial succeeded, you should *at a bare minimum* disclose effect size and stats for primary endpoint.
If a puny biotech had issued a data-free PR like this, @adamfeuerstein would've ripped them a new one.
Wonderful read relevant to the current times both for academic and operational leaders !
The future belongs not to centers that choose between prominence and presence, but to those disciplined enough to achieve both. @JCOOP_ASCO
That's a wrap on the 2026 Hawaii Lung Summit! Huge thanks to our brilliant faculty, speakers, and industry partners for making it such an incredible success. Grateful for the science, the connections, and the momentum we're taking forward. #DAVALung
The real truth is that @sarahaboualaiwi you are the real absolute elite rock that keeps this โญ๏ธ @AminNassarMD going ! The sacrifices are endless and enormous. Could not and would not expect anything less from him :)
Agree @drgandara ! Often times we get too excited on the ICI rechallenge part without realizing there may be NO actual benefit to the patients! This large metanalysis from our group led by @ACortelliniMD addresses that dogma to some extent ! https://t.co/wGV63RtM7k
Along this line please remember that the 838 patient PRAGMATICA Lung trial in acquired resistance comparing Pembro-Ramu to SOC (mainly Doce-Ramu) showed no superiority in OS. "Buyer beware"! @LungMAP
๐จTomorrow! @sitcancer Advances in Cancer Immunotherapy: A Focus on Immunotherapy Toxicity Management. Still time to register: https://t.co/Q3DhQ994gG
Including the Pacific Time version of the agenda should any of you find that helpful/an easier conversion!
๐จTomorrow! @sitcancer Advances in Cancer Immunotherapy: A Focus on Immunotherapy Toxicity Management. Still time to register: https://t.co/Q3DhQ994gG
Including the Pacific Time version of the agenda should any of you find that helpful/an easier conversion!
๐จWe want YOU๐จ
Only a few days remain to submit your research to the @ASCO#ASCOQLTY26@RyanNipp
Share your work on quality improvement, PROs, care delivery, survivorship, digital health, & person-centered cancer care
โฐ Deadline: June 16, 11:59 PM ET
https://t.co/aHUQ2L8xfe
Thrilled to be part of this team awarded $11.5 million @NIH COBRE grant establishing cutting edge immuno omics and immuno engineering capabilities at @OUCollegeofMed@StephensonCC and OU Norman Campus! https://t.co/ep5mCfBFlL